Literature DB >> 12118944

Targeting epidermal Langerhans cells by epidermal powder immunization.

Dexiang Chen1, Lendon G Payne.   

Abstract

Immune reactions to foreign or self-antigens lead to protective immunity and, sometimes, immune disorders such as allergies and autoimmune diseases. Antigen presenting cells (APC) including epidermal Langerhans cells (LCs) play an important role in the course and outcome of the immune reactions. Epidermal powder immunization (EPI) is a technology that offers a tool to manipulate the LCs and the potential to harness the immune reactions towards prevention and treatment of infectious diseases and immune disorders.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12118944     DOI： 10.1038/sj.cr.7290115

Source DB:  PubMed          Journal:  Cell Res        ISSN： 1001-0602            Impact factor:   25.617


  9 in total

1.  Conference report--adjuvants and delivery: improving on vaccine immunogenicity highlights from the viral vaccine meeting; October 25-28, 2003; Barcelona, Spain.

Authors:  Elena Armandola
Journal:  MedGenMed       Date:  2004-01-26

2.  A differential proteome in tumors suppressed by an adenovirus-based skin patch vaccine encoding human carcinoembryonic antigen.

Authors:  Chun-Ming Huang; Zhongkai Shi; Tivanka S DeSilva; Masato Yamamoto; Kent R Van Kampen; Craig A Elmets; De-chu C Tang
Journal:  Proteomics       Date:  2005-03       Impact factor: 3.984

3.  Uptake and presentation of exogenous antigen and presentation of endogenously produced antigen by skin dendritic cells represent equivalent pathways for the priming of cellular immune responses following biolistic DNA immunization.

Authors:  Stephan Sudowe; Sabine Dominitzki; Evelyn Montermann; Matthias Bros; Stephan Grabbe; Angelika B Reske-Kunz
Journal:  Immunology       Date:  2008-09-17       Impact factor: 7.397

Review 4.  Transdermal delivery of proteins.

Authors:  Haripriya Kalluri; Ajay K Banga
Journal:  AAPS PharmSciTech       Date:  2011-03-03       Impact factor: 3.246

Review 5.  Genetic vaccination approaches against malaria based on the circumsporozoite protein.

Authors:  Sandra Scheiblhofer; Richard Weiss; Josef Thalhamer
Journal:  Wien Klin Wochenschr       Date:  2006       Impact factor: 1.704

6.  Exploitation of Langerhans cells for in vivo DNA vaccine delivery into the lymph nodes.

Authors:  E R Tőke; O Lőrincz; Z Csiszovszki; E Somogyi; G Felföldi; L Molnár; R Szipőcs; A Kolonics; B Malissen; F Lori; J Trocio; N Bakare; F Horkay; N Romani; C H Tripp; P Stoitzner; J Lisziewicz
Journal:  Gene Ther       Date:  2014-04-03       Impact factor: 5.250

7.  A microarray MEMS device for biolistic delivery of vaccine and drug powders.

Authors:  Fatemeh Nazly Pirmoradi; Ashish V Pattekar; Felicia Linn; Michael I Recht; Armin R Volkel; Qian Wang; Greg B Anderson; Mandana Veiseh; Sandra Kjono; Eric Peeters; Scott A Uhland; Eugene M Chow
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

8.  Immunological properties of gold nanoparticles.

Authors:  Lev A Dykman; Nikolai G Khlebtsov
Journal:  Chem Sci       Date:  2016-11-16       Impact factor: 9.825

9.  Self-Assembly DNA Polyplex Vaccine inside Dissolving Microneedles for High-Potency Intradermal Vaccination.

Authors:  Jing-Fong Liao; Jin-Ching Lee; Chun-Kuang Lin; Kuo-Chen Wei; Pin-Yuan Chen; Hung-Wei Yang
Journal:  Theranostics       Date:  2017-06-25       Impact factor: 11.556
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.